Researchers identify biomarkers that could be targets for novel drugs to treat glioblastoma

Biomarkers that could be targets for novel drugs to treat glioblastoma brain tumors have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing hope for a cancer that is highly lethal.

Related Keywords

Boston ,Massachusetts ,United States ,Hackensack ,New Jersey ,Chicago ,Illinois ,Williamj Zuercher ,Xiao Song ,Oxford Nanopore ,Lu Jin ,Temozolomide Temodar ,Bassemr Haddad ,Samuela Goldlust ,Emily Henderson ,Vanshika Goenka ,Roham Razaghi ,Beril Erdogdu ,Norah Sadowski ,Rebeccab Riggins ,Daiichi Sankyo ,Mihaela Pertea ,Juliee Pickett ,Lou Gehrig ,Deannam Tiek ,Davidh Drewry ,Carla Alamillo Ferrer ,J Robert Hogg ,Regional Cancer Care Associates ,John Theurer Cancer Center ,National Institutes Of Health ,Northwestern University Feinberg School Of Medicine ,Cornerstone Specialty Network ,University Of North Carolina At Chapel Hill ,Georgetown Lombardi Comprehensive Cancer Center ,Roberth Lurie Comprehensive Cancer Center ,Winston Timp At Johns Hopkins University ,Blood Institute ,National Heart ,Associate Professor ,Associate Director ,Georgetown Lombardi ,Amyotrophic Lateral Sclerosis ,Northwestern University Feinberg School ,Comprehensive Cancer Center ,Winston Timp ,Johns Hopkins University ,Carrowi Wells ,North Carolina ,Chapel Hill ,National Institutes ,Shi Yuan Cheng ,Boston Biomedical ,Brain ,Dancer ,Flood ,Fell ,Ell Death ,Clinical Trial ,Na ,Drugs ,Education ,Genes ,Glioblastoma ,Guanine ,Medicine ,Ncology ,Protein ,Research ,Temozolomide ,Humor ,